This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, L. Articles by Takada, K. Search for Related Content PubMed PubMed Citation Articles by Yang, L. Articles by Takada, K.

Epstein-Barr Virus (EBV)-Encoded RNA Promotes Growth of EBV-Infected T Cells through Interleukin-9 Induction

¹ Department of Tumor Virology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; ² Department of Pathology, Osaka University Medical School, Suita, Japan; and ³ Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan

EBV associates with various T-cell-proliferating diseases such as chronic active EBV infection and nasal lymphoma. In contrast to B cells, which are highly susceptible to EBV infection in vitro, T cells are refractory to EBV infection in vitro, and it has been difficult to examine the effects of EBV infection on T cells. We recently generated EBV recombinants with a selectable marker, which made it possible to select EBV-infected cells even when the efficiency of infection was low. Using the recombinant virus, we found that a human T-cell line, MT-2, was susceptible to EBV infection, and we succeeded in isolating EBV-infected cell clones with type II EBV latency, which was identical with those seen in EBV-infected T cells in vivo. EBV-infected MT-2 cell clones had shorter cell doubling times and higher saturation density than non-EBV-infected counterparts. We found that EBV-positive MT-2 cells expressed higher levels of interleukin (IL)-9 than EBV-negative MT-2 cells at the transcriptional level. It was also demonstrated that EBV-encoded small RNA was responsible for IL-9 expression. Addition of recombinant IL-9 accelerated the growth of MT-2 cells, whereas growth of the EBV-converted MT-2 cells was blocked by treatment with an anti-IL-9 antibody. These results suggest that IL-9 induced by EBV-encoded small RNA acts as an autocrine growth factor for EBV-infected T cells. Analysis of nasal lymphoma biopsies indicated that three of four specimens expressed IL-9. The present findings suggest that EBV directly affects the pathogenesis of EBV-associated T-cell diseases.

This article has been cited by other articles:

				Y. Wu, S. Maruo, M. Yajima, T. Kanda, and K. Takada Epstein-Barr Virus (EBV)-Encoded RNA 2 (EBER2) but Not EBER1 Plays a Critical Role in EBV-Induced B-Cell Growth Transformation J. Virol., October 15, 2007; 81(20): 11236 - 11245. [Abstract] [Full Text] [PDF]

				J. Dupuis, J.-F. Emile, N. Mounier, C. Gisselbrecht, N. Martin-Garcia, T. Petrella, R. Bouabdallah, F. Berger, A. Delmer, B. Coiffier, et al. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d'Etude des Lymphomes de l'Adulte (GELA) study Blood, December 15, 2006; 108(13): 4163 - 4169. [Abstract] [Full Text] [PDF]

				L. Qiu, R. Lai, Q. Lin, E. Lau, D. M. Thomazy, D. Calame, R. J. Ford, L. W. Kwak, R. A. Kirken, and H. M. Amin Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells Blood, October 1, 2006; 108(7): 2407 - 2415. [Abstract] [Full Text] [PDF]

				V. Fok, K. Friend, and J. A. Steitz Epstein-Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling J. Cell Biol., May 8, 2006; 173(3): 319 - 325. [Abstract] [Full Text] [PDF]

				Y. Satou, J.-i. Yasunaga, M. Yoshida, and M. Matsuoka HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells PNAS, January 17, 2006; 103(3): 720 - 725. [Abstract] [Full Text] [PDF]

				T. Nagato, H. Kobayashi, K. Kishibe, M. Takahara, T. Ogino, H. Ishii, K. Oikawa, N. Aoki, K. Sato, S. Kimura, et al. Expression of Interleukin-9 in Nasal Natural Killer/T-Cell Lymphoma Cell Lines and Patients Clin. Cancer Res., December 1, 2005; 11(23): 8250 - 8257. [Abstract] [Full Text] [PDF]

				M. Yajima, T. Kanda, and K. Takada Critical Role of Epstein-Barr Virus (EBV)-Encoded RNA in Efficient EBV-Induced B-Lymphocyte Growth Transformation J. Virol., April 1, 2005; 79(7): 4298 - 4307. [Abstract] [Full Text] [PDF]

				R. S. Esworthy, L. Yang, P. H. Frankel, and F.-F. Chu Epithelium-Specific Glutathione Peroxidase, Gpx2, Is Involved in the Prevention of Intestinal Inflammation in Selenium-Deficient Mice J. Nutr., April 1, 2005; 135(4): 740 - 745. [Abstract] [Full Text] [PDF]